Client Challenge: Logos Technologies, founded by Giles Wilson in 1995, develops software to collect and review early phase clinical trial data. We were introduced to review an unsolicited offer from Instem Plc to acquire Logos.
Approach: Our advice was not to accept the deal but instead to complete a significant software development program and implement it into some major customers. We reopened discussions with Instem a year later and negotiated a better deal on better terms to the satisfaction of both Instem and the shareholders of Logos. We then project managed and led the response of all due diligence and financial forecasting as well as advising on all the commercial issues that arose during that process.
Outcomes (after 18 months):
The deal completed for £5m to the satisfaction of all the Vendors and the acquirer.
“Peter had clearly done this before which I believe was a significant factor in achieving a successful deal. He did a fantastic job of managing this process It’s important to recognise that a sale will have a strain on the business as well as a cost implication and one needs an advisor to manage a deal to prevent purchases from changing the goal post at the 11th hour, Peter’s experience and commitment took complete control of this.” Giles Wilson, CEO, Logos Technologies
“Peter was so helpful, knowledgeable and quick to do whatever was needed. I could not have played my part without him. I had to respond to the due diligence and we had to produce forecasts over and over and over again. Well Peter did all that and he checked everything I did to make sure it was right. I am delighted to say, the deal would not have happened without him. I am happy to give Peter a reference at any time.” Angela King, Commercial Manager
